Eye treatment head gear

- TearScience, Inc.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of an eye treatment head gear according to the present invention;

FIG. 2 is a front view thereof;

FIG. 3 is a rear view thereof;

FIG. 4 is a left side view thereof;

FIG. 5 is a right side view thereof;

FIG. 6 is a top view thereof; and,

FIG. 7 is a bottom view thereof.

The broken line showing a portion of an eye treatment apparatus is included for illustrating environmental structure and forms no part of the claimed design.

Claims

The ornamental design for eye treatment head gear, as shown and described.

Referenced Cited
U.S. Patent Documents
1006945 October 1911 Houston
1924315 August 1933 Hemphill et al.
2891252 June 1959 Lazo
3333586 August 1967 Bellis et al.
4261364 April 14, 1981 Haddad et al.
4778457 October 18, 1988 York
4883454 November 28, 1989 Hamburg
4914088 April 3, 1990 Glonek et al.
4955377 September 11, 1990 Lennox et al.
5030214 July 9, 1991 Spector
5151100 September 29, 1992 Abele et al.
5158082 October 27, 1992 Jones
5251627 October 12, 1993 Morris
5343561 September 6, 1994 Adamo
5368582 November 29, 1994 Bertera
5368591 November 29, 1994 Lennox et al.
5425380 June 20, 1995 Hudson et al.
5496311 March 5, 1996 Abele et al.
5601548 February 11, 1997 Smith et al.
5643336 July 1, 1997 Lopez-Claros
5700238 December 23, 1997 Hyson
5720773 February 24, 1998 Lopez-Claros
5958912 September 28, 1999 Sullivan
5964723 October 12, 1999 Augustine
6024095 February 15, 2000 Stanley, III
6107289 August 22, 2000 Sullivan
6110292 August 29, 2000 Jewett et al.
6112900 September 5, 2000 Adkins, Jr.
6113561 September 5, 2000 Augustine
6153607 November 28, 2000 Pflugfelder et al.
6155995 December 5, 2000 Lin
6181970 January 30, 2001 Kasevich
6193740 February 27, 2001 Rodriguez
6206842 March 27, 2001 Tu et al.
6213966 April 10, 2001 Augustine
6423018 July 23, 2002 Augustine
6425888 July 30, 2002 Embleton et al.
6438398 August 20, 2002 Pflugfelder et al.
6455583 September 24, 2002 Pflugfelder et al.
6482203 November 19, 2002 Paddock et al.
6490488 December 3, 2002 Rudie et al.
6641264 November 4, 2003 Schwebel
6788977 September 7, 2004 Fenn et al.
6827898 December 7, 2004 Fausset et al.
6840954 January 11, 2005 Dietz et al.
6860852 March 1, 2005 Schonenberger et al.
6860880 March 1, 2005 Treat et al.
6874884 April 5, 2005 Schwebel
6882885 April 19, 2005 Levy, Jr. et al.
6886933 May 3, 2005 Schwebel
6908195 June 21, 2005 Fuller
6925317 August 2, 2005 Samuels et al.
6974454 December 13, 2005 Hooven
7001379 February 21, 2006 Behl et al.
7004942 February 28, 2006 Laird et al.
7036928 May 2, 2006 Schwebel
7069084 June 27, 2006 Yee
7108694 September 19, 2006 Miura et al.
7118591 October 10, 2006 Frank et al.
7123968 October 17, 2006 Casscells, III et al.
7211070 May 1, 2007 Soroudi
7231922 June 19, 2007 Davison et al.
7357500 April 15, 2008 Schwebel
7513893 April 7, 2009 Soroudi
20010041886 November 15, 2001 Durkin et al.
20020035345 March 21, 2002 Beck
20020099094 July 25, 2002 Anderson
20020111608 August 15, 2002 Baerveldt et al.
20020128696 September 12, 2002 Pearl et al.
20030056281 March 27, 2003 Hasegawa
20030114426 June 19, 2003 Pflugfelder et al.
20030139790 July 24, 2003 Ingle et al.
20030195438 October 16, 2003 Petillo
20030211043 November 13, 2003 Korb
20030233135 December 18, 2003 Yee
20040076695 April 22, 2004 Gilbard
20040153093 August 5, 2004 Donovan
20050022823 February 3, 2005 Davison et al.
20050119629 June 2, 2005 Soroudi
20050220742 October 6, 2005 Breen
20060018953 January 26, 2006 Guillon et al.
20060030604 February 9, 2006 Elsinger et al.
20060154901 July 13, 2006 Pflugfelder et al.
20060183698 August 17, 2006 Abelson
20060233859 October 19, 2006 Whitcup et al.
20070016256 January 18, 2007 Korb et al.
20070049913 March 1, 2007 Grenon et al.
20070203462 August 30, 2007 Soroudi
20070280924 December 6, 2007 Daniels et al.
20080051741 February 28, 2008 Grenon et al.
20080075787 March 27, 2008 Hibino
20090043365 February 12, 2009 Friedland et al.
20090137533 May 28, 2009 Adkins, Jr.
20090306111 December 10, 2009 Nakamura et al.
Foreign Patent Documents
2679448 September 2008 CA
06269473 September 1994 JP
11221247 August 1999 JP
200278727 March 2002 JP
2006198249 August 2006 JP
99/09965 March 1999 WO
99/58131 November 1999 WO
2004/041134 May 2004 WO
2009064834 May 2009 WO
Other references
  • Mori, A., et al., “Efficacy of the Treatment by the Disposable Eyelid Warming Instrument for Meibomian Gland Dysfunction,” Poster Presentation, Hall A, 1 page.
  • Korb, Donald R., O.D., et al., “Meibomian Gland Dysfunction and Contact Lens Intolerance,” Jnl American Optometric Association, vol. 51, No. 3, Mar. 1980, 9 pages (pp. 243-251).
  • Korb, Donald R. et al., “Increase in Tear Film Lipid Layer Thickness Following Treatment of Meibomian Gland Dysfunction” Lacrimal Gland, Tear Film and Dry Eye Syndromes: Basic Science Clinical Relevance. Adv. Exp. Med. Biol., vol. 350, 1994, 6 pages (pp. 293-298).
  • Sullivan, Benjamin D., et al., “Impact of Antiandrogen Treatment on the Fatty Acid Profile of Neutral Lipids in Human Meibomian Gland Secretions,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, No. 12, 2000, 8 pages (pp. 4866-4873).
  • Goto, E., et al. “Treatment of Non-Inflamed Obstructive Meibomian Gland Dysfunction by an Infrared Warm Compression Device” British Journal of Ophthalmology, BJO Online, http://www.bmjjournals.com/cgi/reprintform, vol. 26, 2002, 6 pages (pp. 1402-1407).
  • Goto, Eiki, et al., “Tear Evaporation Dynamics in Normal Subjects and Subjects with Obstructive Meibomian Gland Dysfunction,” Investigative Ophthalmology & Visual Science, vol. 44, No. 2, Feb. 2003, 7 pages (pp. 533-539).
  • Kuscu, Naci Kemal, et al., “Tear Function Changes of Postmenopausal Women in Response to Hormone Replacement Therapy,” Maturitas 44, 63-68, 2003, 6 pages.
  • Mori, Asako, et al., “Disposable Eyelid-Warming Device for the Treatment of Meibomian Gland Dysfunction,” Jpn J Ophthalmol, vol. 47: 578-586, 2003, 9 pages (pp. 578-586).
  • Olson, Mary Catherine, B.A., et al., “Increase in Tear Film Lipid Layer Thickness Following Treatment with Warm Compresses in Patients with Meibomian Gland Dysfunction” Eye & Contact Lens, vol. 29(2), 2003, 6 pages.
  • Romero, Juan M., et al., “Conservative Treatment of Meibomian Gland Dysfunction,” Eye and Contact Lens, vol. 30, No. 1, 2004, 6 pages (pp. 14-19).
  • Lemp, Michael A., et al., “The Therapeutic Role of Lipids—Managing Ocular Surface Disease,” Refractive Eyecare for Ophthalmologists, vol. 9, No. 6, Jun. 2005, 14 pages.
  • Mitra, M. et al., “Tear Film Lipid Layer Thickness and Ocular Comfort after Meibomian Therapy via Latent Heat with a Novel Device in Normal Subjects” Eye, vol. 19, 2005, 4 pages (pp. 657-660).
  • Minco “Introducing: Thermofoil Heaters” Bulletin HS-202, 9 pages.
  • Unknown, “Anatomy of the Eye and Orbit,” p. 170.
  • Paugh, J.R. et al., “Meibomian Therapy in Problematic Contact Lens Wear,” Entrez PubMed, Optom Vis Sci. Nov. 1990; 68(11): 803-6, 1 page.
  • Tobler, David et al., “Nanotech Silver Fights Microbes in Medical Devices,”0 ND & DI, devicelink.com, 1 page.
  • Unknown, “IFU Manual for PNT Model 1000—Rev H,” 24 pages.
  • Blackie, Caroline A. et al., “Recovery Time of an Optimally Secreting Meibomian Gland,” Cornea, vol. 28, No. 3, Apr. 2009, pp. 293-297.
  • “New Over-the-Counter Dry Eye Drop Now Available to Help Estimated 40 Percent of Americans Who Suffer from Occasional or Chronic Dry Eye” Business Wire News Release, Published Mar. 31, 2008.
  • Gupta, S. et al. “Docetaxel-induced Meibomian Duct Inflammation and Blockage Leading to Chalazion Formation” Prostate Cancer Prostatic Diseases, vol. 10, No. 4, 2007.
  • Aronowicz, J D et al. “Short Term Oral Minocycline Treatment of Meibomiantis” Br. J Opthalmol, vol. 90, No. 7, Jul. 2006.
  • Goto, E. et al, “Treatment of Non-Inflamed Obstructive Meibomian Gland Dysfunction by an Infrared Warm Compression Device” Br J Opthalmol, vol. 86, No. 12, Dec. 2002.
  • “arGentis Licenses Third Treatment for Dry Eye Syndrome” www.businesswire.com, May 12, 2008.
  • Blackie, Caroline A. et al., “Inner Eyelid Surface Temperature as a Function of Warm Compress Methodology,” Optometry and Vision Science, vol. 85, No. 8, Aug. 2008, pp. 675-683.
  • Kokke, K.H. et al., “Oral Omega-6 Essential Fatty Acid Treatment in Contact Lens Associated Dry Eye,” Contact Lens and Anterior Eye, vol. 31, No. 3, 2008, pp. 141-146.
  • Korb, Donald R., Slide entitled “Inner Eyelid Surface Temperature as a Function of Warm Compress Methodology,” from presentation entitled “The Tear Film and Dry Eye States A Fertile Research Area,” University of California at Berkeley, School of Optometry, Apr. 11, 2008. 2 pages.
  • Korb, Donald R. et al., Slide entitled “Inner Eyelid Surface Temperature as a Function of Warm Compress Methodology,” from presentation entitled “The Greatest Anterior Segment Disease and Contact Lens Complications Course,” AOA Meeting, Seattle, Washington, Jun. 27, 2008, 2 pages.
  • Sullivan, David et al., “Do Sex Steroids Exert Sex-Specific and/or Opposite Effects on Gene Expression in Lacrimal and Meibomian Glands?” Molecular Vision, vol. 15, No. 166, Aug. 10, 2009, pp. 1553-1572.
  • Paugh, Jerry R. et al., “Precorneal Residence Time of Artificial Tears Measured in Dry Eye Subjects,” Optometry and Vision Science, vol. 85, No. 8, Aug. 2008, pp. 725-731.
  • Lemp, Michael A. et al., “Blepharitis in the United States 2009: A Survey-Based Perspective on Prevalence and Treatment.” Ocul. Surf, vol. 7, No. 2 Suppl, Apr. 2009, pp. S1-S14.
  • Matsumoto, Yukihiro et al., “The Evaluation of the Treatment Response in Obstructive Meibomian Gland Disease by In Vivo Laser Confocal Microscopy,” Graefes Arch Clin Exp Ophthalmol, vol. 247, No. 6, Jun. 2009, pp. 821-829.
  • Toyos, Rolando, “Intense Pulsed Light for Dry Eye Syndrome,” Cataract & Refractive Surgery Today, Apr. 2009, pp. 1-3.
  • Donnenfeld, Eric et al., “Topical Ophthalmic Cyclosporine: Pharmacology and Clinical Uses,” Survey of Ophthalmology, vol. 54, No. 3, May/Jun. 2009, pp. 321-338.
  • Suzuki, Tomo et al., “Estrogen and Progesterone Control of Gene Expression in the Mouse Meibomian Gland,” Invest. Ophthalmol. Vis. Sci., vol. 49, No. 5, Apr. 2008, pp. 1797-1818.
  • Vasta, Stephanie, “Aggressive Treatments Developed for Meibomian Gland Dysfunction,” Primary Care Optometry News, Nov. 1, 2009, 3 pages.
Patent History
Patent number: D613408
Type: Grant
Filed: Feb 6, 2008
Date of Patent: Apr 6, 2010
Assignee: TearScience, Inc. (Morrisville, NC)
Inventors: Keith H. Gausmann (Cary, NC), Stephen M. Grenon (Durham, NC), Julia Rose Anderson (Melrose, MA), David Chesley (Duxbury, MA)
Primary Examiner: Ian Simmons
Assistant Examiner: Wan Laymon
Attorney: Withrow & Terranova, PLLC
Application Number: 29/303,317
Classifications
Current U.S. Class: Ophthalmic (D24/150)